Stephen Gordon - Feb 1, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Chief Financial Officer
Signature
By: /s/ Stephen Gordon
Stock symbol
TMDX
Transactions as of
Feb 1, 2023
Transactions value $
-$232,500
Form type
4
Date filed
2/3/2023, 04:06 PM
Previous filing
Jan 18, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $80.7K +5K +87.5% $16.14* 10.7K Feb 1, 2023 Direct F1
transaction TMDX Common Stock Sale -$313K -5K -46.67% $62.64 5.71K Feb 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5K -19.43% $0.00 20.7K Feb 1, 2023 Common Stock 5K $16.14 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.